| Model Number |
HEALON GV |
| Medical Device Problem Code |
Device Contamination with Chemical or Other Material (2944)
|
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
04/05/2017
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Implant and explant dates: if explanted, give date: not applicable as this is not an implantable device.Recall number: this complaint is part of the healon recall - report number: 2020664-04/13/17-001-r.As a result of the extensive investigation, a manufacturing deficiency has been identified related to re-introducing uncapped glass cylinder units to the capping process.As a corrective action, internal procedures were updated to not re-introduce uncapped glass cylinder units to the capping process.Additionally, a voluntary recall was initiated on april 13, 2017 because of the possibility, albeit remote, that the healon manufactured between october 8, 2016 and november 10, 2016 may contain glass particles.All pertinent information available to abbott medical optics has been submitted.
|
| |
|
Event or Problem Description
|
|
It was reported that during implantation of an intraocular lens (iol), some crystals were noticed in the healon viscoelastic once injected into the patient's eye.Additional information was received and it was learnt that when they inserted the lens in the eye, they noticed some crystal particles under the microscope.No issues were reported with the iol.Reportedly, the doctor was able to vacuum the particles out.No visual issues and no post-op injuries were reported.The patient was reported being fine.No further information was provided.
|
| |
|
Additional Manufacturer Narrative
|
|
Device available for evaluation? yes.Returned to manufacturer on: 05/16/2017.Device returned to manufacturer? yes.Device evaluation: the viscoelastic healon was returned at the manufacturing site for evaluation.Visual inspection revealed glass particles in the remaining portion of the viscoelastic solution.Additionally, the inner rim of the opening of the glass cylinder, which sits under the aluminium capsule, was observed to be damaged (cracked glass).The probable source of the particles in the healon solution is the damaged glass cylinder.The customer's reported complaint was verified.Retained product evaluation: visual inspection on retained products was performed.The solution was clear and colorless.All components were included in the product, without defects.Manufacturing records review: the manufacturing records for the device were reviewed.The product was manufactured and released according to specification.A search revealed that no similar complaints for this order number have been received.Labeling review: the directions for use (dfu) were reviewed.The directions for use (dfu) adequately provides instructions and precautions along with warnings for the proper use and handling of the device.As a result of the investigation there a product quality deficiency was identified.All pertinent information available to abbott medical optics has been submitted.
|
| |
|
Search Alerts/Recalls
|